H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Ginkgo Bioworks, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Ginkgo Bioworks, Inc.
MARank #FEIN 26-3118890

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPGinkgo Bioworks, Inc.
Total filings79,21288
Certified %98.22%93.18%
Denied %1.09%1.14%
Withdrawn %0.61%1.14%
Cert-withdrawn %0.07%4.55%
Rank#4
Active yearsFY2010–FY2026FY2016–FY2026
Worksite statePAMA

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Ginkgo Bioworks, Inc.

DOL case-status mix.

Outcome breakdown: Certified 93.2%, Cert-withdrawn 4.5%, Withdrawn 1.1%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified93.2%
Cert-withdrawn4.5%
Withdrawn1.1%
Denied1.1%
Certified93.2%
Cert-withdrawn4.5%
Withdrawn1.1%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,357
FY20113,610
FY20124,667
FY20136,024
FY20146,873
FY20157,505
FY20167,371
FY20177,040
FY201816,029
FY20197,724
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20261,792
Ginkgo Bioworks, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20130
FY20140
FY20150
FY20164
FY20176
FY20185
FY20195
FY20202
FY20211
FY20227
FY20236
FY202438
FY202513
FY20261

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.